Position in CYTK
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
10 quarters on record
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Mar 31, 2026CallValue
$3,295,500
CallShares
50,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Jefferies Financial Group Inc. holds $677,219,224 across 66 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTCT |
Ptc Therapeutics, Inc.
|
1,357,042 | $110,693,915 | |
| 2 | URGN |
UroGen Pharma Ltd.
|
2,199,652 | $80,947,193 | |
| 3 | IMTX |
Immatics N.V.
|
6,506,802 | $65,913,904 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
2,010,534 | $62,849,292 | |
| 5 | CGON |
CG Oncology, Inc.
|
769,947 | $54,704,734 | |
| 6 | ARGX |
Argenx SE
|
45,068 | $41,812,738 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
929,626 | $31,040,212 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
466,258 | $26,679,282 |
All Filings in CYTK
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,295,500 | 50,000 | Call | Defined | 2026-05-08 | |
| 2025-12-31 | $3,177,000 | 50,000 | Call | Defined | 2026-02-09 | |
| 2025-09-30 | $2,748,000 | 50,000 | Call | Defined | 2025-11-13 | |
| 2025-06-30 | $1,652,000 | 50,000 | Call | Defined | 2025-08-12 | |
| 2024-12-31 | $592,704 | 12,600 | Shares | Defined | 2025-02-27 | |
| 2024-06-30 | $445,359 | 8,220 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,244,922 | 32,020 | Shares | Defined | 2024-05-13 | |
| 2024-03-31 | $799,254 | 11,400 | Call | Defined | 2024-05-13 | |
| 2023-12-31 | $3,130,875 | 37,500 | Call | Defined | 2024-05-06 | |
| 2023-12-31 | $2,104,615 | 25,208 | Shares | Defined | 2024-05-06 | |
| 2023-06-30 | $1,159,641 | 35,550 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,407,600 | 40,000 | Shares | Defined | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||